Deal-Making

CDMO ten23 health and injection/infusion system developer Ypsomed will make investments to advance commercialization of the YpsoDose wearable injector.

Deal Making

Germfree has bought CGT firm Orgenesis' mobile cleanrooms and has partnered to advance its therapeutic program to boost production capacity.

Facilities & Capacity

CDMO Kincell Bio will support Imugene’s allogeneic CAR-T candidate Azer-cel after acquiring its North Carolina facility for up to $6 million.

Facilities & Capacity

The Boston Institute of Technology and BiBo-Biopharma have completed a 30,000 L fermentation run on the world’s first ultra-large bioreactor.

Global Markets

Regeneron has joined its fellow pharma players in the venture investing space by committing up to $500 million over five years across the healthcare industry.

Global Markets

Africa Centres for Disease Controls (CDC) has accused Moderna of abandoning its commitment to building vaccine manufacturing capabilities in Africa after pausing plans for a plant in Kenya.

Regulations

CDMO AGC Bio will supply lentiviral vectors for Orchard Therapeutics’ metachromatic leukodystrophy (MLD) gene therapy, approved in the US this week.

Global Markets

Global biopharma lobbying organization BIO has forced WuXi AppTec to leave the group due to pressure from the US Congress.

Therapeutic Class

Africa Centres for Disease Controls (CDC) has accused Moderna of abandoning its commitment to building vaccine manufacturing capabilities in Africa after pausing plans for a plant in Kenya.

Facilities & Capacity

UCB says it built out its internal capabilities to create a process intensified AAV production process based on perfusion after finding limitations when working with external partners.

Upstream & Downstream Processing

Nigel Titchener-Hooker, professor and dean of engineering at University College London, guided delegates at BioProcess International Europe in Vienna, Austria, on a tour through drug-development history.

Upstream & Downstream Processing

The growing popularity of digital twins is transforming process intensification in the biopharmaceutical industry.